000283106 001__ 283106
000283106 005__ 20260102094407.0
000283106 0247_ $$2doi$$a10.1186/s12889-025-25531-w
000283106 0247_ $$2pmid$$apmid:41469611
000283106 0247_ $$2pmc$$apmc:PMC12755007
000283106 037__ $$aDZNE-2026-00002
000283106 041__ $$aEnglish
000283106 082__ $$a610
000283106 1001_ $$aCallaway, Julia$$b0
000283106 245__ $$aAgeing populations: new challenges in longevity.
000283106 260__ $$aLondon$$bBioMed Central$$c2025
000283106 3367_ $$2DRIVER$$aarticle
000283106 3367_ $$2DataCite$$aOutput Types/Journal article
000283106 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1767343258_32511
000283106 3367_ $$2BibTeX$$aARTICLE
000283106 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000283106 3367_ $$00$$2EndNote$$aJournal Article
000283106 520__ $$aHigh-income countries experienced unprecedented gains in life expectancy throughout the twentieth century. However, recent evidence suggests that these gains have slowed, especially at older ages. This paper focuses on recent trends in life expectancy and health in ageing populations in high-income countries.We analysed mortality and health data from the Human Mortality Database and the Global Burden of Disease. Additionally, we reviewed recent literature to explore changes in life expectancy, health-adjusted life expectancy, physical and cognitive decline, and the impact of ageing on healthcare expenditure in countries with high life expectancies.Although life expectancy continues to rise in high-income countries, the pace of improvement has slowed, especially among the oldest-old. While health-adjusted life expectancy has generally increased, the proportion of life spent in good health varies across countries, with notable differences in trends in physical and cognitive disabilities. In terms of economic implications, these findings highlight the importance of age and proximity to death as determinants of healthcare expenditures.The deceleration in life expectancy gains, particularly among the oldest populations, raises important questions about future trends in longevity. As physical and cognitive health change in older ages healthcare systems will face new and diverse challenges. Understanding the role of ageing and time-to-death in shaping healthcare costs will be critical for anticipating future needs in high-income countries.
000283106 536__ $$0G:(DE-HGF)POF4-354$$a354 - Disease Prevention and Healthy Aging (POF4-354)$$cPOF4-354$$fPOF IV$$x0
000283106 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000283106 650_7 $$2Other$$aCognitive health
000283106 650_7 $$2Other$$aHealth economics
000283106 650_7 $$2Other$$aHealth expectancies
000283106 650_7 $$2Other$$aMortality
000283106 650_7 $$2Other$$aPhysical health
000283106 650_2 $$2MeSH$$aHumans
000283106 650_2 $$2MeSH$$aLife Expectancy: trends
000283106 650_2 $$2MeSH$$aAged
000283106 650_2 $$2MeSH$$aLongevity
000283106 650_2 $$2MeSH$$aAged, 80 and over
000283106 650_2 $$2MeSH$$aAging
000283106 650_2 $$2MeSH$$aMale
000283106 650_2 $$2MeSH$$aDeveloped Countries: statistics & numerical data
000283106 650_2 $$2MeSH$$aFemale
000283106 650_2 $$2MeSH$$aHealth Expenditures: trends
000283106 650_2 $$2MeSH$$aMiddle Aged
000283106 650_2 $$2MeSH$$aMortality: trends
000283106 650_2 $$2MeSH$$aGlobal Burden of Disease
000283106 650_2 $$2MeSH$$aGlobal Health
000283106 7001_ $$aStrozza, Cosmo$$b1
000283106 7001_ $$aChristensen, Kaare$$b2
000283106 7001_ $$0P:(DE-2719)2811246$$aDoblhammer, Gabriele$$b3$$udzne
000283106 7001_ $$aRau, Roland$$b4
000283106 7001_ $$aSøgaard, Jes$$b5
000283106 773__ $$0PERI:(DE-600)2041338-5$$a10.1186/s12889-025-25531-w$$gVol. 25, no. 1, p. 4395$$n1$$p4395$$tBMC public health$$v25$$x1471-2458$$y2025
000283106 8564_ $$uhttps://pub.dzne.de/record/283106/files/DZNE-2026-00002.pdf$$yRestricted
000283106 8564_ $$uhttps://pub.dzne.de/record/283106/files/DZNE-2026-00002.pdf?subformat=pdfa$$xpdfa$$yRestricted
000283106 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811246$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000283106 9131_ $$0G:(DE-HGF)POF4-354$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Prevention and Healthy Aging$$x0
000283106 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC PUBLIC HEALTH : 2022$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:34:53Z
000283106 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:34:53Z
000283106 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2024-04-10T15:34:53Z
000283106 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-01-07
000283106 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-01-07
000283106 9201_ $$0I:(DE-2719)1012002$$kAG Doblhammer$$lDemographic Studies$$x0
000283106 980__ $$ajournal
000283106 980__ $$aEDITORS
000283106 980__ $$aVDBINPRINT
000283106 980__ $$aI:(DE-2719)1012002
000283106 980__ $$aUNRESTRICTED